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Abstract 
Macrophages derive from multipotent precursor cells and play a critical role in the 
immune response.  They can change states in response to environmental factors and much 
of these have been elucidated from a molecular biological approach.  However, recent 
studies demonstrate that the biomechanical properties of the extra cellular matrix (ECM), 
such as stiffness, can affect the activation state of macrophages and possibly their ability 
to phagocytose.  Phagocytosis, where a cell internalises a foreign object, by macrophages 
is a first line of defence against foreign bodies and is initiated by a receptor-ligand 
interaction which causes the polymerisation of actin to form the phagocytic cup which 
then goes on to become a phagosome.  In this study, RAW264.7 and bone marrow derived 
macrophage (BMDM) cells were exposed to lipopolysaccharides (LPS) fluorescent 
bioparticles and zymosan fluorescent beads to study the phagocytosis process.  The cells 
were investigated using time-lapse imaging and super-resolution microscopy.  To 
understand the effects of ECM stiffness on phagocytosis, the cells were cultured on soft 
and stiff Polydimethylsiloxane (PDMS) elastomers to establish if substrate stiffness 
influences the phagocytic process.  These results demonstrated that PDMS is not a good 
substrate for cell culture stiffness experiments.  Using PDMS alone does not allow cells 
to adhere correctly and utilising ECM proteins as an adherence layer is also not feasible 
for stiffness studies as it negates the stiffness of the underlying substrate at the nanometre 
level.  The live-imaging studies also revealed a possible new mechanism of phagosome 
formation. 
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Project Aims 
To study the effect that the elastic modulus of substrates has on macrophages, specifically 
on their ability to phagocytose. This may correlate to how macrophages react to tissue 
stiffness in tumours or scar tissues.    
Using live cell imaging and super resolution microscopy, the phagocytic process will be 
studied with particular focus on the phagocytic cup and phagosome formation.  Many 
proteins are known to be involved in this process and more have been implicated.  This 
study will look at some of these proteins with what looks to be the first time using super-
resolution microscopy.  Structured illumination microscopy will be utilised to do this in 
order to visualise protein localisation in the macrophage cell lines. 
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1. Chapter 1 - Literature Review 
1.1 Macrophages 
Macrophages are the “Big Eaters” of the innate immune system, ubiquitous, functionally 
diverse cells first described by Metchnikoff in 1892[1][2].  They are phagocytic cells 
which are mainly involved in homeostasis by removing apoptotic cells, clearing of 
cellular debris, the remodelling of tissue after insult and most notably, defence against 
microbes[3]. 
The location of the macrophage populations gives rise to different phenotypes and they 
have been named due to the tissues they reside in.  Macrophages resident in the liver are 
known as Kupffer cells, microglia are resident in the brain, Langerhans cells are found in 
the epithelium to name a few.  In table 1.1, the location of these tissue resident 
macrophages can be seen along with the specialised functions they utilise in these 
locations. 
 
 
Name Function 
Macrophage (Eye) Vascular remodelling 
Alveolar Macrophage 
(Lungs) 
Immune surveillance 
Kupffer Cells (Liver) Debris clearance from blood and liver regeneration 
Crypt Macrophages 
(Intestines) 
Immune surveillance 
Macrophage(Ovaries) Ovulation and hormone production 
Macrophage (Testis) Hormone production 
Osteoclasts (Bone) Bone remodelling 
Microglia (Brain) Debris and dead cell clearance 
Langerhans Cells (Skin) Immune surveillance and keratinocyte differentiation 
Macrophage (Cardiac) Healing and remodelling 
Macrophage (Kidney) Ductal development 
Bone Marrow Macrophage Erythropoiesis 
Macrophage (Mammary) Ductal development and branching 
Macrophage (Spleen) Immune surveillance 
 
Table 1.1 Macrophage phenotype and Function[4] 
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Traditionally, the ontology of macrophages was thought to arise from bone marrow 
monocytes differentiating in tissues to become tissue resident macrophages[5]–[7].  
Although bone marrow monocytes move from the blood and enter tissues differentiating 
into macrophages during times of inflammation, recent research has shown that 
populations of tissue resident macrophages are derived from embryonic progenitors that 
are recruited to tissues during foetal development.  These macrophages persist and 
account for a large amount of tissue-resident macrophages in adults[8], [9].  The ontology 
can be seen below in Figure 1.1. 
 
 
Figure 1.1 illustrates the lineage of macrophages from their multipotent precursor cells to monocytes and 
finally into macrophages and also from their embryonic origin.  (Modified image from Copyright © [2006] [A.  
Rad]) 
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1.2 Activation States 
Macrophages can have different activation states which can change depending on 
environmental conditions.  There are broadly two distinctive phenotypes, classically 
activated or M1 type and alternatively activated or M2 type which are extremes of a wide 
range of functional states[10][11].  Another phenotype of macrophage activation is 
present in tumour tissues, these macrophages represent a major factor in the inflammatory 
microenvironment of cancer and are referred to as Tumour associated macrophages 
(TAMs)[12].   
These activation states can depend on the location of the macrophage in the body as 
certain phenotypes arise from adaption to their location such as microglia in the brain or 
Kupffer cells in the liver.  These phenotypes are advantageous as different tissues require 
altered potencies of defence.  Intestinal macrophages lining the gut for example do not 
need to initiate a chronic immune response that can be detrimental to health[13].  M1 and 
M2 macrophages have been shown to be capable of changing their activation state when 
exposed to different stimulus[14].  This further shows the plasticity of these adaptable 
cells and utilising this ability may be a way to provide a therapeutic effect in some auto-
immune conditions and also possibly to re-programme TAMs to attack cancer cells. 
 
1.2.1 M1 Phenotype Macrophage 
M1 phenotype macrophages are known for their phagocytic ability.  They are able to 
phagocytose a large numbers of units, be it cellular debris or pathogens.  A number of 
stimuli can polarise macrophages to an M1 phenotype, the main three being 
lipopolysaccharide (LPS), Interferon-gamma (IFN- γ) and granulocyte-macrophage 
colony stimulating factor (GM-CSF).  These activated cells can detect pathogens through 
receptors on the cell surface by direct pattern recognition receptors (PRRs) or by indirect 
receptors such as Fc or complement and when the cells become activated they have been 
shown to increase the number or receptors available on the cell surface[15].   
As well as their phagocytic ability, M1 type macrophages produce pro-inflammatory 
cytokines such as tumour necrosis factor (TNF), IL-12, and IL-1β.  An increase in reactive 
oxygen species (ROS) and inducible nitric oxide synthase (iNOS) production are also 
features of an M1 phenotype[16].   
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1.2.2 M2 Phenotype Macrophage 
While M1 type macrophages are involved in destroying and removing pathogens, M2  
type macrophages are anti-inflammatory and promote tissue repair and cell proliferation 
by arginine[17][18].  Some of the stimuli responsible for M2 activation are IL-4, IL-10, 
TGF-β as well as parasitic worms[19].  They have many different roles including, allergy 
response, angiogenesis and tissue remodelling to name a few[16].  The M2 type 
macrophage is further split into three classes, all having similar phenotype but with 
different functions.  The M2a type are involved with the Th2 immune response and are 
known for their response to fungal or parasitic infections.  The M2b type play a role in 
immune regulation and M2c macrophages are heavily involved in tissue remodelling[20].   
 
1.2.3 Tumour-Associated Macrophages 
For a cancerous tumour to have progressed, it must have found a way to supress the 
immune system.  Macrophages found in the tumour microenvironment are known as 
tumour associate macrophages (TAMs).  These are an M2 like class of macrophages and 
contribute to immune suppression.  They do this by production of TGF- β and IL-10 
which affect T-cells[21].  TAMs have been shown to be involved in metastasis, 
angiogenesis, tumour cell proliferation and lead to a poor prognosis[22].  As mentioned 
above, the plasticity of macrophages and the fact that they are not terminally 
differentiated into a particular activation state would suggest that reprogramming TAMs 
to an M1 type like state could possibly be a way of fighting cancer. 
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1.3 Phagocytosis 
Phagocytosis has long been known as a main role of macrophages where they provide a 
first line of defence against foreign bodies as well as the clearing up of apoptotic, 
senescent, or dying cells.  It is the engulfment of particles greater that 500 nm in size into 
a membrane-bound vesicle in the cytoplasm of cells.  Macrophages are particularly 
known for their phagocytosis ability which they utilise in pathogen defence and apoptotic 
cell clearance.  The initiation of phagocytosis begins when receptors on the macrophage 
sense ligands on a pathogen or cellular debris.  The receptor ligand interaction causes the 
membrane to remodel and cup formation to begin.  Pseudopods emerge from the cell 
membrane and reach for the target and eventually wrap around it, pulling it into the 
phagocytic cup.  The cup then closes over the object to form a membrane bound vesicle 
called a phagosome.  The phagosome then is met with lysosomes and endosomes to 
mature into a phagolysosome.  The phagolysosome is an acidic environment similar to 
lysosomes and also contains other microbiocidal components such as hydrolyases, 
peroxidases and proteases, all of which help with pathogen degradation.  Once the 
pathogen has been digested the macrophage expels the debris and begins antigen 
presentation to recruit and activate other immune cells.  Figure 1.2 shows the stages of 
phagocytosis.   
 
 
Figure 1.2 The stages involved in phagocytosis.  Receptor interactions trigger the formation of the phagocytic 
cup to engulf the particle to form a phagosome.  Underhill and Goodridge (2012) 
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Phagocytosis can be initiated in different ways depending on the pathway.  Figure 1.3 
illustrates the most common 2 types, Fc receptor mediated and complement receptor 
mediated phagocytosis. 
 
Figure 1.3 Illustrates Fc receptor mediated and Complement receptor mediated phagocytosis.  Underhill and 
Goodridge (2012) 
There are other receptors responsible for phagocytosis initiation including, scavenger 
receptors, MARCO, CD14, CD36 and dectin-1 receptors. 
 
1.4 Lipopolysaccharides 
Lipopolysaccharides (LPS) are a main component of the outer membrane of gram-
negative bacteria.  They act as a defensive barrier whereby they provide the cell with 
protection from environmental stress, even allowing some bacteria to survive in extreme 
environments[23].  LPS has long been used in immune studies as it is a very strong 
stimulator of the innate immune response in eukaryotes and in high quantities it can cause 
the host to go in to septic shock.   
 
LPS is composed of three parts; an O-antigen, a carbohydrate core and a Lipid A.  It is 
the Lipid A unit that causes the strong immune response due to its activation of the pattern 
recognition receptor (PRR) Toll Like Receptor 4 (TLR4).  Lipid A is not normally 
accessible until the bacterial cell replicates or due to other mechanisms that lead to parts 
of the cell wall to separate.  This allows the Lipid A unit to become extracellular and to 
be picked up by the innate immune system leading to the TLR4 pathway of immune 
response[24]. 
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1.5 Zymosan 
Like LPS, zymosan has been utilised in immune response studies for many decades now.  
It is recovered from the cell wall of a yeast, namely Saccharomyces cerevisiae.  It is also 
a strong stimulator of the innate immune response, but its mechanism of action is different 
to that of LPS.  The phagocytosis of zymosan is facilitated by a range of receptors, most 
notably the mannose receptor (MR).  Conversely, the immune response initiated by 
zymosan is dependent on single a receptor which is a heterodimer of TLR2 and TLR6.  
Interestingly, Underhill et al.  demonstrated that both the phagocytosis and immune 
response are not inter-reliant and one can take place regardless of the other[25]. 
 
1.6 Substrate Influence on Macrophages 
The substrates on which cells are cultured been known to affect cell behaviour for a long 
time.  Many studies have been done showing how stem cells can be differentiated as a 
result of the properties of the substrate they adhere to[26]–[28].  This can be down to a 
number of factors including, stiffness, topography, adhesivity, hydrophobicity, chemical 
composition and binding affinity.  Adherent cells have many integrins which interact with 
substrate ligands to provide traction for the cell.  The strength of this traction lead to 
forces in the cell which can affect cell morphology and cytoskeletal arrangement.  This 
in turn can affect cell function and even gene expression.  Kilian and Mrksich showed 
using RT-PCR that lineage specific gene expression varied across four different 
substrates[27].  Engler et al.  also demonstrated that mesenchymal stem cells commit to 
lineages as dictated by the elasticity of the substrate they were cultured on[28]. 
 
It has been reported that the biomechanical properties of the ECM can affect the activation 
state of macrophages[29].  Most of these studies have used ECM proteins on their 
substrates and not taken this into account when measuring the elastic modulus of the 
substrates.  The stiffness testing that has been done was by tensile tests where they 
stretched the substrates in order to calculate the stiffness or by compression tests[30] on 
a large area of the substrate.  These methods completely ignore the effect of the topical 
ECM proteins and other studies measure the substrates stiffness before coating with an 
ECM protein[31][32].  The affect ECM proteins have on the substrate stiffness does not 
seem to be taken into account in these studies which would question the role stiffness has 
to play in their results. 
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1.7 Proteins Involved in Phagocytosis 
Many proteins are known to be involved in the phagocytic process and many others have 
been implicated.  The proteins of interest for this project are Rac1, RhoA, PTEN, vinculin, 
paxillin, and talin. 
 
1.7.1 Rho GTPase family 
The Rho GTPase family are heavily involved in the control of actin reorganisation which 
is critical for phagocytosis.  The signalling pathways involved in this process are not fully 
elucidated, but once a receptor ligand interaction has been made, actin polymerization 
beneath the site begins.  This actin polymerisation leads to the formation of the phagocytic 
cup and pseudopodia extensions.  The Rho GTPases are responsible for actin filament 
organisation which control the motility and phagocytosis process of engulfment.  The 
most common proteins of the Rho GTPase family involved in the process are Rac1, RhoA 
and Cdc42. 
 
1.7.2 PTEN 
Phosphatase and tensin homolog (PTEN) is a ubiquitous phosphatase.  It is a tumour 
suppressor and its main role is to dephosphorylate PIP3 to form PIP2 which results in 
inhibition of the AKT signalling pathway.  Mondal et al.  demonstrated that depletion of 
PTEN in macrophages resulted in an increased PIP3 expression which led to enhanced 
phagocytosis in vitro and in vivo[33].  Kim et al.  also showed that wildtype PTEN 
completely disabled Fc mediated phagocytosis in Cos 7 cells[34].   
 
1.7.3 Vinculin 
Vinculin is a protein involved in integrin adhesion to the actin cytoskeleton.  It is heavily 
involved in cell-substrate interaction as well as cell to cell interactions.  It has been shown 
to be involved in the phagocytic cup formation[35].  Hagiwara et al.  demonstrated that 
vinculin is involved in phagocytosis where by it binds to Staphylococcus aureus and leads 
to its engulfment[36]. 
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1.7.4 Paxillin 
Like vinculin, paxillin is a protein involved in the adherence of cells to the ECM.  It binds 
to vinculin in focal contacts.  Gitik et al.  showed that phagocytic receptors activate 
phagocytosis though paxillin[37].  It has also been shown that in Fc mediated 
phagocytosis, paxillin phosphorylation increases and its distribution changes from the 
cytoplasm to the cytoskeleton depending on the different phases of phagocytosis[38]. 
 
1.7.5 Talin 
Another cytoskeleton protein involved in cell adherence and cell to cell contact is talin.  
Talin also binds to vinculin where it stabilises the cell to substrate junctions by linking 
the integrins to the acting cytoskeleton.  As the proteins involved in cell adhesion are also 
the proteins mostly involved in phagocytosis, talin had an important role to play in 
phagocytosis.  Previous studies have shown that talin is involved in phagosome forming 
in Fc and complement mediated phagocytosis and that its knockdown specifically reduces 
complement mediated phagocytosis[39].  In Fc mediated phagocytosis, talin co-localises 
with actin where it gathers next to the phagocytic cup.  As well as that, is also found in 
the pseudopodia that begin to engulf and draw the pathogen into the cell membrane in 
which actin is also heavily involved[40]. 
 
 
1.8 Super-Resolution Microscopy 
Microscopy is the study of objects that cannot be seen by the naked eye.  There are many 
factors which can affect the resolution of an optical microscope such as, quality of lenses 
and the alignment of said lenses.  Even if the lens was 100% perfect in quality and 
alignment, the microscope resolution is still only as good as its diffraction limit.  In 1873, 
Abbe discovered that the resolution of an optical system depended on the wavelength of 
light, the refractive index of the material and the maximum angle against the axis which 
can still get into the objective of the lens being used.  Using these he came up with an 
equation to calculate the theoretically possible resolution of a microscope. 
𝑑 =  
𝜆
2𝑛sin𝜃
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Where d is the resolution of the microscope, 𝜆 is the wavelength of light and nsinθ is the 
numerical aperture of the lens being used.  Green light has a wavelength of around 500 
nm, if it was imaged with an objective with an NA of 1 for example, it would give a lateral 
resolution of around 250 nm.  This seems like a very small size but 250 nm is relatively 
large for the biological study of proteins which require much smaller resolutions to be 
able to image their localisation correctly.  For this reason, super-resolution microscopy 
will be will be utilised in this study. 
Over the last couple of decades there have been significant developments in “breaking” 
the diffraction limit of light to increase the resolving power of microscopes.  The point 
spread function (PSF) as seen in figure 1.4 is a result of the diffraction of light.  It blurs 
the light source image creating an Airy disk which makes it difficult to see the actual size 
of the light source and even to differentiate if it is one single point source or many. 
 
 
Figure 1.4 A simulated image of the PSF showing the actual pinpoint light source on the left and the resulting 
image as seen through the microscope objective due to the diffraction limit of light. 
 
Today there are many instruments and techniques for overcoming the diffraction limit of 
light and it is now possible to successfully achieve lateral resolutions of around 10 nm 
which makes super-resolution ideal for looking at the proteins involved in the 
phagocytosis process.   
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1.8.1 Structured Illumination Microscopy  
Structured Illumination microscopy (SIM) is a fluorescence imaging technique that uses 
moiré patterns to construct a Fourier transform containing more frequencies than would 
be normally available.  It does this by shining different patterns of light on the sample in 
order to create a moirés effect.  The frequency domain is then reconstructed into a super-
resolution image.  Advances in this technique can get down to resolutions of about 50 nm 
both laterally[41].  As well as that, sample preparation is the same as it is for widefield 
fluorescence microscopy.  The major drawback with SIM is the length of time it takes to 
capture the images and to reconstruct them afterwards.  For this reason, it is more suited 
to fixed cell imaging.  Figure 1.5 shows a comparison of a widefield image compared to 
a SIM image. 
 
Figure 1.5 Raw264.7 cells with pHrodo LPS bioparticles (red), actin in green (phalloidin) and the cell nucleus in 
blue (DAPI).  The widefield image is on the left and the SIM image is on the right is much superior in its 
resolution. 
1.8.2 Stimulated Emission Depletion Microscopy 
Another method of overcoming the diffraction limit is with the use of stimulated 
emission depletion (STED) microscopy.  This technique uses a high power laser in a 
ring shape around the excitation laser in order to bleach all other fluorophores except 
the one of interest inside the ring which can be excited as normal with the excitation 
laser.  The ring power can be increased or decreased to allow minimising of the 
illumination at the point of interest which increases the resolution[42].  Stefan Hell won 
the 2014 Nobel Prize in chemistry for the development of this technique.  Advances in 
this method have been shown to achieve resolutions down to 2.1 nm[43]. 
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1.8.3 Single Molecule Localisation Techniques 
There are many other techniques based on single molecule localisation methods such as 
stochastic optical reconstruction microscopy (STORM)[44] and photoactivated 
localisation microscopy (PALM)[45].  Both of these are widefield techniques and work 
by stochastically activating fluorophores through multiple cycles and rapidly capturing 
many images which can be reconstructed to show each fluorophore as it was activated.  
This allows the software to assume that each source of light was from one fluorophore 
only which creates a super-resolution image.  This method can get to 10 nm lateral 
resolution[46].   
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2. Chapter 2 - Methods 
The project required two cell lines and one primary cells to be cultured and maintained.  
For imaging, staining needs to be optimised, and substrates of choice need to be prepared 
to grow and image cells on them.  The substrate stiffness also needs be measured. 
2.1 Raw 264.7 cell line 
These are a macrophage-like cell line derived from Balb/c mice.  They preserve many of 
the properties of macrophages such as phagocytosis of beads and Zymosan, high nitric 
oxide (NO) production, are very responsive to TLR agonists and they also possess 
suitable motility for study.  They are capable of being transfected.  The cell line was 
received from Dr Fiona Semple at the Institute of Genetic and Molecular Medicine, 
Edinburgh.  The cells were cultured in T75 flasks with Dulbecco's Modified Eagle 
Medium (DMEM) supplemented with 10% heat inactivated foetal bovine serum (HI-
FBS) and pen/strep.  This model has been one of the main cell lines utilised for 
macrophage studies for many years. 
2.2 Passaging cells 
When cultures were 70-80% confluent they were passaged as follows.  Spent culture 
medium was discarded and the cell layer was washed with DPBS.  Fresh media was added 
and cells were scraped to remove them from the flask substrate.  Appropriate aliquots 
were taken (usually a 1:4 to 1:6) and resuspended in fresh media in a new culture vessel 
and placed in an incubator at 37 °C with 5% CO2. 
2.3 Cell fixation and immunofluorescence staining 
Media and reagents were warmed to room temperature and spent culture medium was 
aspirated and discarded.  Cells were grown on square 22mm glass coverslips, each one 
placed in a well of a 6-well plate.  The coverslips were firstly washed with DPBS and 
then incubated for 20 mins with 4% Polyformaldehyde (PFA) to fix the cells.  The 
coverslips were then washed in triplicate with DPBS to remove any PFA.  They were then 
incubated for 5 mins with 0.2% Triton X-100 in order to permeablize the cells, once 
permeabilized they were again washed in triplicate with DPBS.  If antibodies were being 
used, the coverslips were incubated in a blocking buffer for 10 mins to stop unspecific 
binding, before being washed in triplicate with DPBS.   
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100 µl of primary antibodies were then added and incubate for 1-24 h depending on 
supplier recommended instructions and incubate at 4 OC.  They were then washed in 
triplicate with DPBS before addition of 100 µl of secondary antibodies and left to incubate 
for 20 mins (DAPI and phalloidin can be also added at this stage if required).  Finally, 
they were washed in triplicate with DPBS and mounted to microscope slide using 10 µl 
of mowiol cell side down and allowed to dry.  The coverslips were then sealed with 
varnish and allowed to dry before imaging. 
2.4 Resuscitating Cells 
Media was warmed to 37 oC using a water bath.  A frozen cell vial was removed from 
storage and the contents were thawed quickly in the 37 oC water bath.  Using aseptic 
technique in a biological hood, the cells were pipetted into 10 ml of preheated media in 
an appropriate tube for centrifugation and spun at 80 g for 2 mins.  Supernatant was 
aspirated to remove DMSO and the pellet was re-suspended in 10 ml of warmed media.  
A viable cell count was done using a Becton Dickson cell counter and cells were 
transferred to a correctly labelled T75 flask with date, initials, cell line and passage 
number.  It was then placed in an incubator set to 37 oC and 5% CO2 conc.  Cells were 
then monitored daily and split when 70-80% confluent. 
2.5 Freezing Cells 
When cultures were 70-80% confluent they were frozen down as follows.  Spent culture 
medium was removed and put aside to make freezing media.  The cell layer was washed 
with DPBS and fresh media was added.  The cells were gently scraped to remove them 
from the flask substrate and then transferred to a 15 ml falcon tube.  A cell count was 
performed using a Becton Dickson cell counter.  Cells were then spun down.  Freeze 
media was made by combining 45% cell conditioned media with 45% fresh media and 
adding 10% DMSO.  When the cells were spun down, media was removed, and the pellet 
was resuspended in freeze media to give a cell concentration of 5 x 106 cells/ml.  1 ml 
was then added to cryovials and placed in a Mr.  Frosty which causes cells to be frozen 
slowly at 1 °C /min when placed in a -80 °C freezer.  After 24 hr, they were then 
transferred to liquid nitrogen storage. 
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2.6 PDMS substrates  
Sylgard 184 PDMS ratios of 5:1, 10:1 and 20:1 elastomer to curing agent mix were chosen 
to show a range of substrate stiffnesses.  The mixtures were stirred thoroughly before 
being degassed to remove any air bubbles out of the mixture in a vacuum degasser.  They 
were then poured into a 35 mm petri dish to a thickness of ~3mm and once again degassed.  
Once all bubbles had been removed, they were cured in an oven at 65 °C for 1 hour.  
Following curing, the plate was oxygen plasma treated using a Diener Electronic surface 
plasma system.  The substrates were then covered with ethanol to prevent recovery before 
being cultured with cells. 
2.7 Fixed Phagocytosis Assay 
RAW264.7 cells were seeded at a concentration of 1.25 x 105 cells/well in a 6-well plate 
containing glass coverslips and placed in an incubator for 48 h at 37 oC and 5% CO2.  
After 48 h, LPS Bioparticles or zymosan beads were added and it was placed back in the 
incubator for the desired time.  The cells were then fixed and stained as above. 
2.8 Live Phagocytosis Assay 
Cells were seeded at a concentration of 1.25 x 105 cells/dish in a 35mm glass bottom dish 
and placed in an incubator for 48 h at 37 oC and 5% CO2.  After 48 h, the dish was taken 
to the microscope and placed in the incubation chamber on a Nikon A1R Laser Scanning 
Confocal Microscope.  The time-lapse was initiated and LPS Bioparticles or zymosan 
beads were added. 
2.9 Isolation of Murine Bone Marrow Derived Macrophages 
Enteroendocrine L-cells were grown to confluence in DMEM with 10% HI-FBS with 
100IU/ml penicillin and 100ug/ml streptomycin.  The flasks were sealed and incubated 
for 3 weeks at 37oC and 5% CO2.  The L-cell conditioned media was recovered and 
sterilised by filtration using a 0.25 um filter and stored at 4 oC.  This media contains CSF-
1 which is needed for bone marrow derived macrophage (BMDM) differentiation. 
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Femoral bone marrow cells were isolated from 50% C57BL6J and 50% FvB mice for 
Rac-1 FRET and 87.5% percent C57BL6J 3rd generation back cross from initial 
transgenic mouse for RhoA FRET.  They were flushed with syringes from the bone using 
RPMI macrophage growth medium which contained 10% HI-FBS, 100 IU/ml penicillin, 
100 µg/ml streptomycin, 1x non-essential amino acids, 1mM Sodium pyruvate and 8.5 µl 
of B-mercaptoethanol, supplemented with 10% L-cell conditioned media.  Cells were 
seeded at 1 x 106 cells/ml in a 25 cm2 bacterial plastic dish and incubated at 37 oC and 
5% CO2.  After 3 days, non-adherent cells were collected and cryogenically frozen as 
above for later use as these cells have a limited proliferation life span. 
2.10 Atomic Force Microscopy 
AFM was carried out using an JPK Nanowizard 3 Bioscience optimised for live cell 
imaging, mounted on a Zeiss Axio Observer D1 Microscope completely contained in an 
acoustic enclosure.  A Hertz contact model, a pyramidal gold coated tip with force 
constant of 0.3734N/m and angle of 35 degrees along with a set point of 5nN and a scan 
rate of 1Hz were utilised.  The experiment was carried out three times on three separate 
days and >30 different contact points were measured for each sample. 
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3. Chapter 3 - Results and Discussion 
The first step was to optimise the antibodies chosen for the project with the RAW264.7 
cell line.  The phagocytic assay was then developed and tested with fixed and live imaging 
followed by super-resolution microscopy of the fixed samples.  The live imaging led to 
an investigation of phagocytic vesicles seen in the phagocytosis process that was not 
expected.  Concurrently, a substrate was chosen and tested for substrate stiffness 
experiments with the cells. 
3.1 Proteins of Interest 
Three adhesion associated proteins were chosen for study; talin, vinculin and paxillin.  
The antibodies were optimised by using a 1/200th and a 1/500th dilution of the primary 
antibodies with representative images shown in figure 3.1 and table 3.1.  Each 
experiment was done in triplicate and repeated on three separate days. 
 
Figure 3.1 RAW264.7 cells were fixed and stained with paxillin, vinculin and Talin primary antibodies along 
with Alexa Fluor 405 (Blue) and Alexa Fluor 647 (Pink) secondary’s for Talin, and Alexa Flour 568 secondary 
for paxillin and vinculin.  Phalloidin (Green) was also used to stain for actin and DAPI (Blue) was used to stain 
the nucleus in vinculin and paxillin.  Scale bar shown is 20 µm. 
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Antibody 1/200th Dilution 1/500th Dilution 
Paxillin Good Weak 
Vinculin Good Weak 
Talin Good Good 
Table 3.1 Antibody Optimisation.  Optimal dilutions for each antibody highlighted in green. 
 
3.1.1 Talin 
The talin 1&2 (abcam) antibody staining worked successfully at 1/200th dilution and at 
1/500th which mean 1/500th dilution will work for the planned experiments.  Both of the 
secondary antibodies were successful which is very useful as it means we can stain at 
the 405 nm and also in the far red at 657 nm.  As a result, we have the capability to 
perform four colour immunofluorescence staining which will be very beneficial as it 
will be possible to image actin in green with 488 nm and zymosan beads in red with 561 
nm.   
3.1.2 Vinculin 
The Pierce vinculin antibody (Novex, 42H89L44) staining worked successfully for the 
primary and also for the 568 secondary antibody.  The 1/500th dilution required a longer 
exposure time and more laser power which produced some noise in the image, 
therefore, a 1/200th dilution will be utilised for the experiments with this antibody. 
3.1.3 Paxillin 
The paxillin antibody (Novex, 5H11) staining worked successfully for the primary and 
also for the 568 secondary antibody.  As with the vinculin antibody, the 1/500th dilution 
required a longer exposure time and more laser power which caused noise in the image, 
consequently, a 1/200th dilution will be employed for the experiments with this 
antibody. 
Once the PDMS substrate adherence is addressed, these proteins will be studied on each 
of the substrates 
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3.2 Phagocytosis assay 
Cells were seeded onto glass coverslips and after 48 h they were exposed to tagged Cy3 
zymosan beads for 2h followed by fixing and staining by phalloidin for actin visualisation 
and DAPI for the nucleus.  This was done to see if it was possible to visualise the different 
stages of the phagocytosis process using fixed imaging.  These experiments were done in 
triplicate and repeated on three separate days. 
 
 
Figure 3.2 Raw264.7 cells showing phagocytosed cy3 tagged zymosan (red) after 1h incubation, actin in green 
(phalloidin) and the cell nucleus in blue (DAPI).  Scale bar shown is 20 µm. 
The Raw264.7 cells successfully phagocytosed the beads after a 2h incubation.  This 
assay was successful and will allow a time point assay to be carried out by choosing times 
from the time-lapse images.  Times will be chosen so cells can be fixed to capture the 
different stages of phagocytosis as some of the proteins of interest may not be involved 
in all stages of phagocytosis. 
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Time-lapse imaging of zymosan phagocytosis was carried out using the RAW264.7 cell 
line.  Brightfield was used for the cells and a 561 nm laser was used for the zymosan 
beads.  Figure 3.3 shows the phagocytosis process from cup formation to engulfment.   
Table 3.2 shows a breakdown of the number of cells that phagocytosed beads over a 2h 
period as well as how many beads were phagocytosed and how many cells did not 
phagocytose any beads.  A total of 111 cells were analysed using ImageJ.  The cells 
phagocytosed 96 beads over 2 hours and 55% of the cells had phagocytosed after a 2h 
period.  This will be repeated on each of the substrates to see if substrate stiffness affects 
phagocytosis in macrophages. 
 
Figure 3.3 RAW264.7 cells showing phagocytosed cy3 tagged zymosan.  These stills are taken from a time-lapse 
to show the phagocytosis process.  Scale bar shown is 5 µm   
 
Number of 
Cells 
Beads 
phagocytosed 
Cells with 
no beads 
Average 
Beads per 
cells 
% cells that 
phagocytosed 
Run 1 47 38 26 1.8 44.7 
Run 2 32 32 12 1.6 62.5 
Run 3 32 26 12 1.3 62.5 
Total 111 96 50 1.6 55 
Table 3.2 RAW264.7 cells showing phagocytosed cy3 tagged zymosan.  These results are taken from a time-lapse 
to show the phagocytosis process over a 2h period. 
 
Further data analysis optimisation of the time-lapse images was carried out using imageJ 
(Figure 3.4) to measure the morphological characteristics of the macrophages after 
exposure to the zymosan beads.  Graph A shows the total surface area of the macrophages 
which has one peak to suggest not much variance in cell spreading between the cells.  
Graph B illustrates the roundness or circularity of the cells.  Values of 1 demonstrate a 
circular morphology and values <1 suggest an irregular or elongated shape.  Graph C 
shows the perimeter of the cells and this follows a similar pattern to the macrophage 
surface area with one main peak.   
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There are two strong peaks at ~0.45 and ~0.85 as well as a smaller peak at ~0.65 which 
suggest two populations of morphologies which isn’t surprising as the cells can quickly 
go from a spherical shape to an elongated morphology depending on if they have 
phagocytosed or are reaching to interact with a bead and they have also been seen to do 
this regardless of any stimulus.  This analysis can be carried out on the time-lapse images 
which will be done on the different stiffness substrates and all of the data compared. 
 
Figure 3.4 Graphs show the frequency distribution of the morphology of RAW264.7 cells after 2h exposure to 
zymosan beads.  Graph A shows the total surface area of the macrophages which has one peak to suggest not 
much variance in cell spreading between the cells.  Graph B illustrates the roundness or circularity of the cells.  
Values of 1 demonstrate a circular morphology and values <1 demonstrate an irregular or elongated shape.  
Graph C shows the perimeter or circumference of the cells and this follows a similar pattern to the macrophage 
surface area with one main peak (N=3). 
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3.3 Super-resolution Microscopy 
The optimised vinculin antibody was also imaged using Super-resolution microscopy 
with the Nikon N-SIM microscope.  It gave extremely well resolved images of vinculin 
showing its focal point of adherence to the substrate as seen in red in Figure 3.5.  This 
will be repeated at different stages of the phagocytic process and also on the different 
stiffness substrates. 
 
Figure 3.5 RAW264.7 cells were cultured on coverslips and incubated for 48 h before being fixed and stained 
with Vinculin primary antibody with a secondary Alexa flour 568 nm antibody.  Phalloidin (Green) was also 
used to stain for actin and DAPI (Blue) to stain the nucleus. 
 
Images of the LPS Bioparticles which had been endocytosed (not phagocytosed as less 
than 500 nm) were also optimised using the N-SIM instrument.  These images can be 
seen in figure 3.6. 
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Figure 3.6 Raw264.7 cells showing endocytosed pHrodo LPS bioparticles (red) after 1h incubation, actin in green 
(phalloidin) and the cell nucleus in blue (DAPI).  These images were taken as part of the optimisation of the SIM 
system for the cell line.  Scale bar shown is 5 µm 
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3.4 Substrate Stiffness 
Three ratios of PDMS were utilised for the experiment 5:1, 10:1 and 20:1 as they 
represent a range of stiffnesses.  As macrophages are found all over the body, the 
stiffnesses they encounter are varied so no specific elastic moduli were chosen for this 
study.  Previous studies have also used these ratios for cell experiments and found that a 
10:1 ratio has the greatest elastic modulus.  A 10:1 ratio is the manufacturer’s 
recommended ratio and indicates this is the optimal concentration of cross linker.  Ratios 
lower then 10:1 would have an excess of crosslinker which results in a lower elastic 
modulus in the 5:1 ratio[47, p. 2].  Conversely, the 20:1 ratio has less crosslinker available 
than the 10:1 and therefore also has a lower elastic modulus.  The AFM results of the 
plasma treated substrates reflects this pattern.  The 5:1 ratio measured 42 MPa, 10:1 
measured 76 MPa and the 20:1 measured 58 MPa.  These results fall within the range of 
expected values for plasma treated PDMS[48].  The plasma treatment causes a stiff layer 
to form on the PDMS which increases the elastic modulus of the substrate[48]. 
 
RAW264.7 macrophage cells were cultured directly onto the substrates and incubated to 
see if the cells would adhere to PDMS or if another option would be needed to help 
adherence.  After 48 h the cells were fixed and stained with phalloidin and DAPI as above.  
Figure 3.7 shows the fluorescence imaging along with graphs of cell surface area, 
roundness and perimeter length.  These experiments were done in triplicate and repeated 
on three separate days. 
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Figure 3.7 A.  RAW264.7 Macrophages grown on 5:1, 10:1 and 20:1 PDMS substrates.  After 48 h of 
incubation, cells were fixed and stained with actin in green (phalloidin) and the cell nucleus in blue (DAPI).  B 
Average surface area of cells was measured and graphed.  C Roundness of cells was calculated and graphed.  
D Perimeter of cells was measured and graphed for each substrate.  Graphs show mean ± SEM (*** -> 
P<0.001, ** -> P<0.01 and *->P<0.05) Scale bar shown is 20 µm (N=3). 
 
In comparison to culture on glass, the cells did not seem to adhere to the substrates very 
well with only sparse populations adhering throughout the substrate.  The cells 
morphology was similar for 5:1 and 10:1 PDMS ratios with the 20:1 having a statistically 
significant greater spreading of cells as shown by their lower roundness value.  The 
surface area of cells on the 5:1 substrate was significantly larger than the other two 
substrates, but the perimeter length was greater in the 20:1 substrate which suggests an 
elongated morphology.  This was most likely down to the hydrophobicity of the PDMS 
substrates as the wettability of 5:1 and 10:1 was noticeably much less than that of the 
20:1.   
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The next step was to find another way to treat the PDMS so the surface would be less 
hydrophobic and the cells would be more likely to adhere.  Wang et al.  oxidised the 
PDMS surfaces using oxygen plasma which reduces the hydrophobicity of the 
substrates[47].  This was carried out using a Diener Electronic surface plasma system.  
Treating the PDMS with oxygen plasma creates hydrophilic silanol groups (SiOH) but 
these hydrophilic functional groups are short lived in normal atmosphere as the substrate 
will recover back to its original hydrophobic nature[49].  Covering the treated substrate 
with ethanol or de-ionized water can help to prevent recovery.   
 
 
Figure 3.8 A.  RAW264.7 Macrophages grown on 5:1, 10:1 and 20:1 plasma treated PDMS substrates.  After 
48 h of incubation, cells were fixed and stained with actin in green (phalloidin) and the cell nucleus in blue 
(DAPI).  B Average surface area of cells was measured and graphed.  C Roundness of cells was calculated and 
graphed.  D Perimeter of cells was measured and graphed for each substrate.  Graphs show mean ± SEM (*** 
-> P<0.001, ** -> P<0.01 and *->P<0.05) Scale bar shown is 20 µm (N=3). 
 
 
 
27 
 
After plasma treating the PDMS substrates, the cells adhered much better than they did 
on non-plasma treated PDMS.  From the images and graphs in figure 3.8, the cells 
cultured on the plasma treated PDMS substrates had a morphology comparable to how 
they look cultured on glass, having a greater surface area, a more elongated shape and 
also a larger perimeter, suggesting better cell adherence and spreading.   
The results from each of the morphology studies on PDMS and Plasma treated PDMS 
are compared and seen in figure 3.9.  The morphology of the cells on the 5:1 substrate, 
which seems to be the more hydrophobic of the substrates changed when the surface 
was plasma treated.  The cells were significantly more elongated on the plasma treated 
surface and also their perimeter length was statistically longer suggesting cell spreading.  
Conversely, the roundness of cells on the 20:1 plasma treated substrate was greater than 
that of the no treated substrate.  Hydrophobicity testing could be done on the PDMS and 
plasma treated PDMS substrates to see how much the plasma treatment changes the 
hydrophobicity of all three substrates.  It may just be effective for the 5:1 substrate as 
there is not much of a difference noticed between treated and not treated substrates for 
the 10:1 substrate. 
From a purely cell culture point of view, the plasma treated substrates could be used as 
a cell culture substrate as the cells can adhere more successfully than they could on non-
treated PDMS but for the PDMS substrates to be utilised for fixed and time-lapse 
imaging of the macrophages, it would not be successful as the adherence is not great 
enough to endure washing steps involved in microscopy preparation.  In order to use the 
substrates to see how the substrate stiffness can alter the macrophages ability to 
phagocytose, another method to help the cells adhere to the substrate needs to be 
employed.   
To remove the issue of hydrophobicity, previous studies have coated the surface of the 
substrates with ECM proteins such as fibronectin, collagen, or laminin[47].  Laminin was 
chosen as it is found in the foundation of most cells and organs.  The above experiment 
was repeated three times and again the morphology was similar across all three PDMS 
substrates.   
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Figure 3.9 A comparison of cells cultured on PDMS and plasma treated PDMS substrates.  A.  Average surface 
area of cells was measured and graphed.  B.  Roundness of cells was calculated and graphed.  C Perimeter of 
cells was measured and graphed for each substrate.  Graphs show mean ± SEM (*** -> P<0.001, ** -> P<0.01 
and *->P<0.05) (N=3). 
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Figure 3.10 Illustrates the morphology of RAW264.7 cells cultured for 48 h on glass (B) and on laminin coated 
glass (A).  C Surface areas of cells was measured and graphed.  D Roundness of cells was calculated and graphed 
for each substrate.  E Perimeter of cells was measured and graphed.  Graphs show mean ± SEM (*** -> P<0.001, 
** -> P<0.01 and *->P<0.05) Scale bar shown is 20 µm (N=3). 
 
The effect of laminin on the morphology of the cells can be clearly seen in Figure 3.10.  
The laminin caused more cells to adhere than on PDMS substrates alone but they 
remained very spherical in shape with no cell spreading noticed.  In comparison, cells 
seeded directing onto glass have a very different morphology where they are stretching 
and reaching with pseudopodia.  The surface area and perimeter length of the cells was 
statistically much greater in cells on the glass substrate.  The average roundness of the 
cells statistically differed between substrates also, with the cells on laminin being much 
more circular in shape. 
 
 
 
30 
 
Previous studies have used ECM proteins on their substrates but this seems to alter the 
stiffness of the substrate as seen by the cells[47].  The stiffness testing that had been done 
on these substrates had been by tensile tests where they stretched the substrates in order 
to calculate the stiffness.  This method seems to ignore the effect the topical ECM proteins 
may have on the substrate stiffness.  In order to see if coating the substrate with an ECM 
protein had an effect on the stiffness, the substrates were coated with 1 ml of 50 µg/ml of 
Laminin and the elastic modulus of the substrate was measured using AFM.  Substrates 
were prepared and measured taking at least 30 measurements at different locations on the 
substrate for each sample.  This experiment was repeated on three separate days.  The 
AFM probe indented approximately 200-250 nm on laminin coated substrates, and only 
approx.  20 nm on PDMS only substrates.  The results showed that the stiffnesses of the 
substrates was drastically altered by the addition of the ECM protein.  Coating the PDMS 
substrates with laminin reduced the elastic modulus for, 5:1 from 42 MPa to 345 kPa, 
10:1 from 76 MPa to 1.4 MPa and for the 20:1 from 58 MPa to 320 kPa as seen in figure 
3.11 The difference in elastic modulus was statistically significant for all three substrate 
ratios compared to the laminin coated substrates with P<0.0001.  A glass cover slip was 
also coated with laminin and its elastic modulus was measured.  This reduced the elastic 
modulus of glass from the gigapascal range to 441 kPa.  The results for the plasma treated 
PDMS substrates fall in the range of values as previously measured by Mills et al.[48]. 
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Figure 3.11 Atomic Force Microscopy was used to measure the elastic modulus of the PDMS substrates and also 
of laminin coated PDMS substrates.  The results suggest that the laminin coating adds a "cushion" effect  which 
negates the underneath substrate’s stiffness, defeating the purpose of the proposed experiment.  Graph shows 
mean ± SEM (*** -> P<0.001, ** -> P<0.01 and *->P<0.05) (N=3). 
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There is a variance between the elastic modulus of 10:1 laminin coated substrate in 
comparison to the other three laminin coated substrates.  Although the difference is not 
statistically significant, a frequency distribution of the 10:1 laminin data was analysed 
as seen in figure 3.12 and revealed that there was a broad range of values which would 
suggest that the substrate may not have been uniformly coated with the laminin and thus 
has a greater mean than the other substrates. 
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Figure 3.12 Frequency distribution of the 10:1 Laminin coated PDMS substrates showing a range of values 
suggesting a non-uniform coating of laminin (N=3).   
 
The AFM results clearly demonstrated that coating the substrate with laminin 
completely alters the stiffness of the substrate and for this reason it should not be used 
for substrate stiffness experiments.  Table 3.33 shows that there is statistical difference 
between the substrate stiffness pre-laminin coating but after coating the substrates there 
is no significant difference between the different substrates.  Interestingly there is no 
significant difference between the laminin coated substrates and a laminin coated glass 
cover slip which suggests that the laminin creates a topical layer on the substrates and 
the underlying substrate has little to do with stiffness on a nanometre level.  The AFM 
probe indented the substrate by approximatively 200-250 nm on the laminin coated 
substrates, but only by approximately 20 nm on the plasma treated only samples 
suggesting a greater stiffness in the non-coated samples as expected. 
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Bonferroni's Multiple 
Comparison Test 
Significant? P < 
0.05? 
Summary 
5:1 vs 10:1 Yes *** 
5:1 vs 20:1 Yes *** 
10:1 vs 20:1 Yes *** 
   
5:1 vs 5:1 Laminin Yes *** 
10:1 vs 10:1 Laminin Yes *** 
20:1 vs 20:1 Laminin Yes *** 
   
5:1 Laminin vs 10:1 Laminin No ns 
5:1 Laminin vs 20:1 Laminin No ns 
10:1 Laminin vs 20:1 Laminin No ns 
   
5:1 Laminin vs Glass Laminin No ns 
10:1 Laminin vs Glass Laminin No ns 
20:1 Laminin vs Glass Laminin No ns 
Table 3.3 Table of AFM data using a Bonferroni post-hoc test. 
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3.5 Phagocytic Vesicles 
From the time-lapse images of the phagocytosis assay, the phagocytic process ensues as 
expected from literature except for one extra part that has been noted.  After the cup has 
formed and the pseudopodia have engulfed the bead, it is taken into the cytoplasm where 
it has now become a phagosome.  In some of the cells, there is a premade vesicle that is 
moved up to where the cup has formed, and the bead is forced into this vesicle to form a 
phagosome.  Figure 3.13 shows this snapshot taken from a time-lapse.   
 
 
Figure 3.13 RAW264.7 cells showing phagocytosed cy3 tagged zymosan.  These stills are taken from a time-lapse 
to show the phagosome vesicle fusion process.  The vesicle is pointed out with the green arrows.  Scale bar shown 
is 10 µm. 
 
The traditional model for phagocytosis states that the membrane bound vesicle or 
phagosome is formed from the cell membrane when it is pinched on engulfment of the 
particle into the cytoplasm.  In the image at 3m20s it is hard to see any membrane 
surrounding the bead.  After the fusion of the bead and the premade vesicle at 3m28sec it 
is clear to see the bead has been engulfed by the vesicle.  This is clearly seen in the final 
image which looks like the traditionally expected phagosome. 
The phagocytic model says that lysosomes fuse with the phagosome to form a 
phagolysosome this is expected to be later in the process and not just as the bead is 
phagocytosed.  The vesicle seemed too big to be a lysosome but lysotracker was used to 
confirm if it could possibly be a lysosome.  Figure 3.14 shows the cells incubated with 
lysotracker showing the lysosomes in the cell.  The vesicles of interest do not fluoresce 
suggesting they are not lysosomes.  Further investigation will need to be done on these 
vesicles to see exactly what they are. 
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Figure 3.14 RAW264.7 cells showing Lysotracker in red to show lysosomes in the cells.  The vesicles are pointed 
out with the green arrows and show no fluorescence suggesting they are not lysosomes.  Scale bar shown is 10 
µm. 
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4. Chapter 4 - Conclusion 
The above studies on the substrate experiments demonstrate that coating the PDMS 
substrates with laminin negates the stiffness of the substrate underneath.  This would 
suggest that any stiffness studies being carried out would need to be done without using 
an extracellular matrix such as laminin, collagen or any other which adds an extra layer 
on the substrates.  Another option also needs to be employed to overcome the 
hydrophobicity of the substrate.  The oxygen plasma treatment seemed to be a promising 
method but due to the nature of PDMS and its plasma treatment recovery, this is not a 
valid option due to too much variability in the substrates.  Taking all this into account, it 
seems like PDMS is not a suitable substrate for stiffness experiments especially when 
used for mammalian cell culture work.  A different substrate type will have to be chosen 
and recent studies have shown that hyaluronic acid may be a good substrate.    
It is possible to see that both the antibody staining, and the super-resolution imaging have 
been optimised and are ready for use on the substrates once suitable substrates are chosen.  
The phagocytic assay has been optimised very successfully for both fixed and time-lapse 
imaging and the use of SIM super-resolution microscopy has shown good resolution of 
the proteins of interest which will allow the phagocytic cup formation to be imaged in 
great detail.  As well as that, the time-lapse imaging has revealed that a premade vesicle 
in the cytoplasm is responsible for the phagosome in some macrophages.  This differs 
from the classical mechanism of phagocytosis and was an unexpected discovery. 
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5. Chapter 5 - Future Studies 
During my time conducting the above research, many areas of interest for possible other 
studies presented themselves.  If I were to continue with the studies, these are the areas I 
would like to consider further; 
5.1 Substrate Stiffness 
Due to the variability of PDMS an alternative suitable substrate would need to be utilised 
to study the effect of substrate stiffness on macrophages, the stiffnesses can be measured 
using AFM as above and the surfaces could be compared using electron microscopy to 
see if surface porosities differ which may have an effect on cell adherence.  The 
hydrophobicity of the substrates would need to be measured by contact angle 
measurements as this also may have an effect on cell interactions with the substrate as 
was seen by the difference in hydrophobicity of the PDMS substrates of different ratios. 
RAW264.7 and BMDM cells could then be cultured on these substrates and on glass 
where they would be treated with LPS Bioparticles and Zymosan to see if substrate 
stiffness has an effect on the macrophages’ ability to phagocytose.  The above time-lapse 
imaging could be repeated for each of the substrates to see how stiffness affects the rate 
of phagocytosis, pseudopodia migration as well as macrophage motility.   
As antibodies have already been optimised for the RAW264.7 cell line, it would be 
possible to stain the cells on the new substrates and see if the expression of vinculin, 
paxillin, RhoG and talin differ across the different stiffness substrates utilising confocal 
and SIM super-resolution microscopy.  To finish out the substrate work, ELISAs could 
be performed on the cultured cells to see if the substrate stiffness has an effect on the 
macrophage activation state as it may cause them to become M1 type activated or more 
M2 type activated. 
These results could suggest that the different stiffness ECMs encountered by 
macrophages in vivo such as scar and cancerous tumour tissues can influence 
macrophages’ ability to phagocytose and also their activation state. 
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5.2 Phagocytosis Study 
Phagocytosis could also be looked at in more detail using super-resolution microscopy 
on both the N-SIM and STORM Nikon systems.  Using these instruments, it would be 
possible to see the proteins involved in phagocytosis, particularly, the phagocytic cup 
formation in more detail and higher resolution than has previously been achievable using 
traditional microscopy techniques.   
Myosin isoforms are known to be involved in phagosome internalisation and are very 
important for the movement of vesicles and other particles along actin fibres which are 
imperative for phagocytosis.  The Rho GTPase family have also been recognised to be 
important for cytoskeleton remodelling during the phagocytosis process.  With this in 
mind, the RAW264.7 and THP-1 cell lines could be transfected for actin and myosin so 
time-lapse imaging can be done to see the phagocytosis process in action from cup 
formation to internalisation.  The isolated murine BMDM containing RhoA and Rac1 
FRET probes could also allow the investigation of how RhoA and Rac1 are involved in 
the phagocytosis process as the regulation of actin dynamics is mostly controlled by the 
Rho GTPase family.  It would also be possible to compare fixed samples at various stages 
of the phagocytic engulfment progression focusing on talin, paxillin, vinculin and RhoG 
with super-resolution microscopy in order to elucidate their role in the process.   
 
5.3 Vesicle fusion 
As well as that, I would like to look in more detail at the initial large vesicle/endosome 
fusion with the phagosome as seen in the time-lapse images already captured.  As stated 
above, I have already used lysotracker to see if these vesicles were acidic in nature, but 
they did not appear to be so.  Further research would need to be done to find out exactly 
what these vesicles are and what their involvement is in the phagocytic process.     
Ultimately, the goal would be to use the research gathered on phagocytosis with the 
intention of applying it to a cancer model and see how cancer cells/tumours can affect the 
macrophages’ ability to phagocytose cancer cells.  This would be a very important study 
as it could allow the possibility of activating the macrophages to attack the cancer or even 
prevent the cancer from metastasising and forming secondary tumours somewhere else in 
the body.   
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